Back to Search
Start Over
Trevena Reports Second Quarter 2024 Results and Provides Business Update
- Source :
- GlobeNewswire. August 8, 2024
- Publication Year :
- 2024
-
Abstract
- TRV045, novel S1P receptor modulator in development for the treatment of acute and chronic neuropathic pain and epilepsy, demonstrated sustained long-term analgesic effect and differentiated mechanism of action in preclinical [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.804185885